SEQIRUS

Manufacturing Influenza vaccines

Filings
46
Clients
1
Total Income
Years Active
2016–2026

Filings

Year Client Period Income Expenses Doc
2024 SEQIRUS 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$220,000
2023 SEQIRUS 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$190,000
2023 SEQIRUS 2nd Quarter (Apr 1 - June 30)
AMENDED
$220,000
2023 SEQIRUS 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$410,000
2023 SEQIRUS 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$190,000
2023 SEQIRUS 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$210,000
2022 SEQIRUS 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$230,000
2022 SEQIRUS 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$250,000
2022 SEQIRUS 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$120,000
2022 SEQIRUS 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$130,000
Prev Page 2 of 5  ·  46 filings Next

Clients Represented

ClientFilingsTotal Income
SEQIRUS 46

Lobbyists

NameDisclosed Prior Position
CHRISTINE FARQUHARSON OMB, Health Division, Program Examiner (2010-2021)
PHYLLIS FROSST
AMY WALKER Deputy Scheduler, Sen. John Warner, 2008; Assistant to the Chief of Staff, Sen. Jim Risch, 2009